BaroFold

About:

BaroFold is a biopharmaceutical company focused on the development of protein therapeutics for immunology indications.

Top Investors: Boulder Ventures, HBM Healthcare Investments, The Peierls Foundation

Description:

BaroFold is a privately held biopharmaceutical company focused on the development of commercially attractive protein therapeutics for immunology indications. The company's goal is to discover, develop and commercialize protein biologics, some of which incorporate its proprietary PreEMTâ„¢ high pressure folding technology along with other state-of-the-art technologies. This pipeline contains therapeutics with an Immunology focus, including Multiple Sclerosis, Rheumatoid Arthritis, and Asthma.

Total Funding Amount:

$17.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Aurora, Colorado, United States

Founded Date:

2003-01-01

Contact Email:

info(AT)barofold.com

Founders:

Matt Brewer, Matthew Seefeldt

Number of Employees:

1-10

Last Funding Date:

2013-02-20

IPO Status:

Private

Industries: